Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-05-008027
Filing Date
2005-02-24
Accepted
2005-02-23 20:25:13
Documents
10
Period of Report
2004-12-29

Document Format Files

Seq Description Document Type Size
1 10-K a05-3421_110k.htm 10-K 1798408
2 EX-4.4 a05-3421_1ex4d4.htm EX-4.4 57642
3 EX-4.5 a05-3421_1ex4d5.htm EX-4.5 58528
4 EX-10.18 a05-3421_1ex10d18.htm EX-10.18 30725
5 EX-23.1 a05-3421_1ex23d1.htm EX-23.1 4397
6 EX-23.2 a05-3421_1ex23d2.htm EX-23.2 9482
7 EX-31.1 a05-3421_1ex31d1.htm EX-31.1 15470
8 EX-31.2 a05-3421_1ex31d2.htm EX-31.2 14307
9 EX-32.1 a05-3421_1ex32d1.htm EX-32.1 8819
10 EX-32.2 a05-3421_1ex32d2.htm EX-32.2 7377
  Complete submission text file 0001104659-05-008027.txt   2007862
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 303-516-8500
TAPESTRY PHARMACEUTICALS, INC (Filer) CIK: 0000891504 (see all company filings)

EIN.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24320 | Film No.: 05635633
SIC: 2833 Medicinal Chemicals & Botanical Products